Personalis, Inc. (PSNL) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PSNL currently has 104M outstanding shares. with significant dilution risk as 123M authorized shares could dilute existing holders by 117.6%. The company has significantly diluted shareholders by 78.65% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 104.2M shares outstanding |
100M | 120M |
| Nov 04, 2025 |
10-Q filing | 88.7M shares outstanding |
89M | 140M |
| Aug 05, 2025 |
10-Q filing | 88.5M shares outstanding |
89M | 140M |
| May 06, 2025 |
10-Q filing | 87.5M shares outstanding |
87M | 140M |
| Feb 27, 2025 |
10-K filing | 88.3M shares outstanding |
88M | 140M |
| Feb 27, 2025 |
S-3 filing: This is an S-3 filing for the offer and resale of 14,044,943 shares of common stock by selling stockholders, who received these shares in a private placement on December 19, 2024; the company will not receive any proceeds from the sale. |
71M | 160M |
| Nov 06, 2024 |
10-Q filing | 70.6M shares outstanding |
71M | 140M |
| Aug 30, 2024 |
S-3 filing: This S-3 filing registers 3,500,000 shares of common stock for resale by selling stockholders, who received the shares in a private placement on August 16, 2024; the company will not receive any proceeds from the sale. |
52M | 160M |
| Aug 07, 2024 |
10-Q filing | 52.4M shares outstanding |
52M | 160M |
| May 08, 2024 |
10-Q filing | 50.7M shares outstanding |
51M | 160M |
| Feb 28, 2024 |
10-K filing | 48.2M shares outstanding |
48M | 160M |
| Dec 21, 2023 |
S-3 filing: This S-3 filing covers the offer and resale of up to 9,218,800 shares of common stock issuable upon exercise of warrants that were issued to the selling stockholders in a private placement on November 28, 2023. |
49M | 160M |
| Dec 21, 2023 |
S-3 filing: Personalis, Inc. may offer and sell up to an aggregate amount of $200,000,000 of any combination of shares of our common stock, shares of our preferred stock, debt securities and warrants to purchase any of such securities, in one or more offerings. |
49M | 160M |
| Nov 28, 2023 |
8-K filing: Personalis, Inc. entered into a Commercialization and Reference Laboratory Agreement with Tempus Labs, Inc. and issued warrants to Tempus to purchase up to 9,218,800 shares of the Company's common stock. |
49M | 14M |
| Nov 07, 2023 |
10-Q filing | 48.7M shares outstanding |
49M | 14M |
| Aug 08, 2023 |
10-Q filing | 47.7M shares outstanding |
48M | 15M |
| May 03, 2023 |
10-Q filing | 46.7M shares outstanding |
47M | 16M |
| Feb 23, 2023 |
10-K filing | 45.7M shares outstanding |
46M | 17M |
| Nov 02, 2022 |
10-Q filing | 45.9M shares outstanding |
46M | 17M |
| Aug 03, 2022 |
10-Q filing | 45.6M shares outstanding |
46M | 17M |
| May 04, 2022 |
10-Q filing | 45.4M shares outstanding |
45M | 18M |
| Feb 24, 2022 |
10-K filing | 45.0M shares outstanding |
45M | 18M |
| Nov 04, 2021 |
10-Q filing | 44.8M shares outstanding |
45M | 18M |
| Aug 04, 2021 |
10-Q filing | 44.4M shares outstanding |
44M | 19M |
| May 05, 2021 |
10-Q filing | 43.9M shares outstanding |
44M | 19M |
| Feb 25, 2021 |
10-K filing | 43.7M shares outstanding |
44M | 19M |
| Dec 30, 2020 |
S-3 filing: The filing is an S-3 registration statement to register an offering of up to $300,000,000 in common stock, preferred stock, or debt securities and 1,774,240 shares of common stock offered by the selling stockholder. |
35M | 28M |
| Nov 05, 2020 |
10-Q filing | 35.5M shares outstanding |
35M | 26M |
| Aug 06, 2020 |
10-Q filing | 31.7M shares outstanding |
32M | 29M |
| Jul 02, 2020 |
S-3 filing: The filing is an S-3 form for a shelf offering of common stock, preferred stock, and debt securities, as well as common stock offered by selling stockholders, for a total amount of $250,000,000. |
31M | 30M |
| May 07, 2020 |
10-Q filing | 31.3M shares outstanding |
31M | 0 |
| Mar 25, 2020 |
10-K filing | 31.5M shares outstanding |
31M | 0 |